Search - tctmd.com

Displaying 401 - 420 of 664

Sort: Relevancy | Date

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

May 18, 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

May 17, 2018

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

News Conference News HRS 2018

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

May 11, 2018

TCTMD’s Top 10 Most Popular Stories for April 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

April 30, 2018

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

‘Striking’ Rise in TAVR Among Patients With Previous CABG

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

April 13, 2018

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

April 11, 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

March 19, 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

March 11, 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

March 10, 2018

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

March 05, 2018

TCTMD’s Top 10 Most Popular Stories for February 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

March 01, 2018

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Industry News

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

February 20, 2018

More Data Hint at the Superiority of 3-D Imaging for LAA Occlusion

News Daily News

More Data Hint at the Superiority of 3D Imaging for LAA Occlusion

Yael L. Maxwell

February 08, 2018

CABG Results in Better Long-Term Outcomes Than PCI for Younger Patients with Three-Vessel Disease

News Daily News

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Yael L. Maxwell

February 06, 2018

Ischemic Stroke Risk After Acute MI May Last Longer Than Previously Thought

News Conference News ISC 2018

Ischemic Stroke Risk After Acute MI May Last Longer Than Previously Thought

January 29, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.